Acute kidney injury, adrenal insufficiency, pseudohyperkalemia (hemolysis, thrombocytosis), medications (list above).
Heparin-induced hyperkalemia is a potentially life-threatening side effect that requires careful monitoring and prevention. By understanding the risks and taking steps to mitigate them, healthcare providers can minimize the risk of hyperkalemia and ensure safe anticoagulation therapy. heparin and hyperkalemia
The primary cause of this condition is , where heparin inhibits the production of aldosterone in the adrenal glands. This occurs through several specific pathways: The primary cause of this condition is ,
While heparin-induced aldosterone suppression can occur in healthy individuals, resulting in only mild, transient hyperkalemia, clinical significance typically arises in patients with compounding risk factors: While common side effects like bleeding or heparin-induced
The risk and severity of hyperkalemia vary depending on the formulation of heparin used.
Heparin-induced hyperkalemia is an under-recognized but clinically significant electrolyte disorder where the administration of heparin—either unfractionated (UFH) or low-molecular-weight (LMWH)—leads to an elevation of serum potassium levels. While common side effects like bleeding or heparin-induced thrombocytopenia (HIT) are widely known, the impact on potassium homeostasis occurs in approximately . Mechanism of Action: The Adrenal Link